Hamostaseologie

Papers
(The TQCC of Hamostaseologie is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation156
Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism62
Simply Online? Lessons from Virtual Scientific Conferences for the Post-COVID-19 Era54
GTH 2025 ARTE: The Art in Science – Curiosity and Creativity35
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report22
COVID-19: Cardio-pulmonary and Vascular Manifestations22
Theme Issue: “Critical Management Decisions in Hemostasis and Thrombosis”17
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)17
Inherited Platelet Disorders: A Short Introduction17
Treatment of Atypical Clots14
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria13
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism13
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz13
GTH News12
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect12
11
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation11
Hemostaseology in Pediatrics10
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig10
Haemostaseological pearls9
9
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko9
8
Identification of novel cryptic epitopes uncovers a distinct and consistent open ADAMTS13 conformation in iTTP7
GTH News7
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?7
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)7
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction7
Thromboinflammation as a Driver of Venous Thromboembolism7
Determination of thrombotic risk in patients with antiphospholipid syndrome using a modified thrombin generation assay6
Novel heterozygous termination variants causing von Willebrand disease type 16
Mim8 Prophylaxis Beyond Bleeding: Investigating Multifaceted, Patient-reported Outcomes for Hemophilia A in the FRONTIER2 Study6
Platelet Phosphoproteomic Profile Behind Anti-thrombotic Effects of Atypical Chemokine Receptor ACKR36
ITAM upregulation in platelets after major surgery6
Platelet-dependent hemostatic potential in the presence of DOACs5
Assessment of plasma levels of D-dimer and prothrombin fragment 1+2 in patients on direct oral anticoagulants versus vitamin K antagonists5
A novel assay to quantify extrinsic tenase complexes in body fluids5
Asundexian and milvexian: Pharmacodynamic insights from coagulation assays5
The change in factor VIII therapy in Germany - a follow-up retrospective data analysis from smart medication ScanDoc over four years5
The dynamic range of immunoassays for heparin-induced thrombocytopenia5
Comparing thrombin generation in hemophilia A and patients with non-valvular atrial fibrillation on oral anticoagulation4
Aspects of long-term joint health in haemophilia A: inSight Joint Health tool4
Real-World Effectiveness and Usage of Recombinant Factor IX Fc: Interim Analysis in Paediatric Patients from the 24-Month, Prospective, Non-Interventional B-MORE Study4
Hemophilia B Leyden: Characteristics and natural history in the PedNet Registry4
Platelet activating histone/anti-histone immune complexes are associated with a new entity of thrombosis and thrombocytopenia syndrome4
One year practical experience in factor VIII gene therapy4
Characteristics of patients with bleeding disorder of unknown cause in a cohort of patients with mild to moderate bleeding disorders4
Plasma factors might interfere with platelet function in patients with decompensated liver cirrhosis4
Emicizumab Real-World Use in Pediatric Patients: Insights from the German GEPHARD Registry4
Massive portal vein thrombosis due to platelet-activating PF4 antibodies without proximate heparin exposure, infection, or SARS-CoV-2 vaccination3
Feasibility of tests for sports motor skills (general fitness, proprioception and balance) in patients with hemophilia and association with pain and orthopedic joint status3
Women and Hereditary Bleeding Disorders3
Cold-storage of amotosalen-UVA pathogen-reduced buffy-coat platelet concentrates for up to 21 days: identification of emerging platelet subpopulations with different functional potential3
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis3
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia3
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien3
Combining Diagnostics and Research in an Academic Laboratory3
Tolerance Breakdown in Hemophilia A Mice is Orchestrated by Bacterial Infection Modulating Antigen-Specific B and T cell Responses3
Investigating the impact of oligogenic variation on severity of bleeding in hypofibrinogenemia3
Damoctocog Alfa Pegol in German Patients With Severe and Non-Severe Haemophilia A: Fifth Interim Analysis of the Real-World HEM-POWR Study3
Basic Concepts and Indications of CAR T Cells3
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management3
Emicizumab for All Pediatric Patients with Severe Hemophilia A3
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics3
High Prevalence of Acquired Platelet Secretion Defects in Multiple Myeloma3
Modification of fibrinolytic potential after cessation of combined oral contraceptives3
Natural IgM antibodies reduce the prothrombotic potential of post-translationally modified collagen3
A Review of FXIa Inhibition as a Novel Target for Anticoagulation3
Interventional Treatment Options in Children with Extracranial Vascular Malformations3
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei3
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism3
Aktueller Stand zur Reform der Gebührenordnung für Ärzte (GOÄ) und Veranstaltung des BDDH auf der 69. Tagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Lausanne 20253
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung2
2
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)2
Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period2
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert2
Management of Disseminated Intravascular Coagulation in Acute Leukemias2
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause2
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life2
Platelet Reduction in Rats Exposed to Chronic Hypoxia Is Associated with Interaction of Glycoprotein Ib Alpha von Willebrand Factor2
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice2
Interim Analysis of Joint Outcomes in Adult and Adolescent Patients with Severe Hemophilia A Receiving Efanesoctocog Alfa During the Phase 3 XTEND-ed Long-Term Extension Study2
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten2
Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms2
Efgartigimod hilft bei Immunthrombozytopenie2
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies2
Anti-inflammatory Strategies in Atherosclerosis2
Platelets in Myocardial Ischemia/Reperfusion Injury1
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far1
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia1
Nachtrag zur kritischen Diskussion über das Deutsche Hämophilieregister (DHR) anlässlich der GTH-Jahrestagung in Frankfurt 2023, aktuelle Informationen zur Gefährdung der Versorgung mit Blutplasmaprod1
Update on Cancer-Associated Venous Thromboembolism in Children1
Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy1
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?1
Evaluation der Vertriebswegänderung und der gesetzlichen Folgeänderungen für Gerinnungsfaktorenzubereitungen; Digitalisierung im Gesundheitswesen: Elektronische Patientenakte; Aktueller Stand bzgl. ne1
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline1
1
Komplementdysregulation als Biomarker für Post Covid1
A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy1
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces1
Editorial1
GTH News1
Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung1
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India1
Does a Simple Blood Gas Analysis and the Clinical Impression Predict Trauma-Induced Coagulopathy?1
VTE Risk Assessment and Prevention in Pregnancy1
Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report1
iTTP in der Schwangerschaft: Erfolgreiche Behandlung mit Caplacizumab1
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH1
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology1
Direct Oral Anticoagulants for Pulmonary Embolism1
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms1
Pulmonary Hypertension and COVID-191
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence1
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert1
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline1
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline1
Diagnosing Inherited Platelet Disorders: Modalities and Consequences1
Markers of Hereditary Thrombophilia with Unclear Significance1
Impact of Thrombophilia Testing on Clinical Management: A Retrospective Cohort Study1
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives1
Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline1
GTH News1
Pulmonary Embolism: Don't Start Me to Talkin'1
Digital Technologies in Hereditary Coagulation Disorders: A Systematic Review1
Subsegmental Pulmonary Embolism1
Cardiovascular Risk Assessment in COVID-191
Acid Treatment of FVIII-Containing Plasma Samples Unmasks a Broad Spectrum of FVIII-Specific Antibodies in ELISA1
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience1
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations1
Treatment of Cancer-Associated Thrombosis: An Update1
0.11540293693542